CAS 623165-93-5

2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.0 3,8]trideca-3(8),4,6-triene] 1,1-dioxide

CAS : 623165-93-5

2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.0^3,8^]trideca-3(8),4,6-triene] 1,1-dioxide is a synthetic compound characterized by its complex spirocyclic structure and multiple trifluoromethyl groups. This type of compound is typically derived through a series of advanced organic synthesis techniques involving multiple reaction steps to achieve its intricate molecular architecture. The presence of trifluoromethyl groups suggests enhanced metabolic stability and increased lipophilicity, which are desirable traits in drug design.

Formule : C₂₅H₃₁F₆N₃O₂S

Degré de pureté : Min. 95%

Masse moléculaire : 551.6 g/mol

Ref: 3D-YZA16593

MRK003

CAS : 623165-93-5

MRK003, a γ-secretase inhibitor, induces apoptosis, halts cell growth in myeloma/NHL, and affects notch signaling and PI3K/Akt pathway.

Formule : C₂₅H₃₁F₆N₃O₂S

Couleur et forme : Solid

Masse moléculaire : 551.59

Ref: TM-T68980